Feature Article: How Artificial Intelligence (AI) Could Change the Future of Epilepsy Care
It seems that everywhere we turn, every show we see, every article we read, Artificial Intelligence (AI for short) seems to pop up! We hear that AI is set to revolutionize life as we know it, although experts are not sure if this will be for good or bad or both. On one hand, it is believed that AI will bring amazing advances to life, quickly and efficiently facilitating and solving an endless array of issues and day-to-day problems, but, on the other hand, some fear that it may leave an uncertain number of individuals unemployed, kids who don’t know how to write by themselves anymore, and even some especially dire predictions of the end of the world as we know it!
What is AI anyhow?
AI is basically a technology that helps computers learn, make decisions, and solve problems in ways that be similar to human intelligence — but often faster and more accurately than people can.
In healthcare, AI can quickly analyze a patient’s medical history, test results, and scans to spot patterns that might be missed by the human eye.
AI and epilepsy care
So, with that in mind, how about we examine how AI might benefit those living with epilepsy and seizures?
Despite some of the concerns mentioned above, most believe that AI is poised to transform epilepsy care in areas including diagnosis, treatment, seizure monitoring, safety, and quality of life for patients of all ages, from infants to older adults. Advances in machine learning (ML), deep learning (DL), and multimodal AI—often analyzing electroencephalograms (EEG), wearable devices, imaging, and clinical data—promise faster, more accurate, and personalized interventions while reducing the trial-and-error burden that has affected many patients in the past.
The potential for improved diagnosis:
Epilepsy diagnosis often relies on interpreting complex EEG recordings, which can be time-consuming and vary from one clinician to the next, especially in under-resourced areas or for complex cases. AI models, such as convolutional neural networks (CNNs) and systems like SCORE-AI, are showing promise in achieving accuracy comparable to or exceeding human experts in classifying normal vs. abnormal EEGs, detecting epileptiform activity, and distinguishing epilepsy from psychogenic non-epileptic seizures (PNES).
Furthermore, with AI, analysis of routine or long-term EEGs can be automated, potentially shortening time to diagnosis by months or years, flagging cases for specialist review, and improving consistency. Also, in pediatric and adult populations alike, AI can aid in localizing seizure onset zones from EEG, MRI, PET, or multimodal data, helping identify surgical candidates earlier.
Seizure Detection, Prediction, and Monitoring:
One of the most promising areas is real-time or predictive monitoring, which directly enhances safety and reduces anxiety of the unexpected.
• Detection: AI analyzes EEG (scalp or intracranial), video, or heart rate and body movement to detect seizures with high sensitivity/specificity (often 90-99% in controlled settings). These automated tools can alert caregivers quickly, which is particularly useful during sleep when many seizures and SUDEP risks are present.
• Prediction: Models forecast seizures minutes to potentially hours in advance using patient-specific patterns from wearables (e.g., smartwatches predicting ~75% of seizures with low false alarms) or EEG. Pre-seizure warnings could allow patients to take precautions, rest, or trigger preventive actions.
Wearables, implants (e.g., responsive neurostimulation), and camera-based systems (using computer vision for movement detection with >99% accuracy in some cases) are becoming more accessible too. This will favor continuous home monitoring rather than hospital stays.
For children and families, this could mean fewer disrupted nights and reduced injury risk; for adults and seniors, greater independence and confidence in daily activities out of the home or when living alone.
Personalized Treatment and Precision Medicine:
AI excels at handling large, complex datasets to move beyond one-size-fits-all approaches.
• Medication selection: Models predict responsiveness to anti-seizure medications (ASMs) based on clinical data, genetics, imaging, and prior responses, potentially reducing the common trial-and-error process (which can take years and cause side effects). Early studies show high accuracy in forecasting which drugs are likely to work for focal or genetic epilepsies.
• Surgical and device optimization: AI localizes seizure foci more precisely (e.g., 65-79% accuracy in mapping or outcome prediction, outperforming some clinician baselines) and helps select candidates for surgery, ablation, or neuromodulation. Personalized deep brain stimulation or responsive devices can adapt in real-time using AI-driven feedback.
• Drug discovery: AI accelerates screening of compounds using neuron arrays or behavioral data, identifying efficacy and side effects faster than traditional methods, which is crucial for rare or drug-resistant epilepsies affecting children and adults.
Quality of Life, Safety, and Broader Benefits:
• Safety: Predictive alerts and automated detection reduce seizure-related injuries, SUDEP risk, and emergencies.
• Daily living: More precise seizure monitoring and greater seizure control and warnings foster independence, employment, and social participation.
• Equity and efficiency: In low-resource settings (e.g., lacking specialized epilepsy monitoring units), AI could bridge gaps in specialist access through automated EEG review or telemedicine integration.
Lastly, administrative AI tools (e.g., producing medical notes during the visit) could free up clinicians for more patient time.
Research and long-term care:
AI can uncover subtle biomarkers, behavioral patterns, or multimodal insights (e.g., from video or multi-sensor data) that humans might miss. This will accelerate our understanding of epilepsy mechanisms and prognosis for all ages.
Considerations for the Future: While promising, challenges remain, including data bias, regulatory approval, privacy concerns, and ensuring equitable access (e.g., device affordability and digital literacy). Models are going to need to be validated in real-world, prospective settings, and human oversight will remain essential.
In other words, AI can improve rather than replace clinicians.
Ongoing research into wearables and implantable devices and multimodal AI suggests these benefits could accelerate in the coming years, potentially making proactive, personalized epilepsy management the norm. Patients and families should be prepared to discuss emerging tools with their neurologists as they become clinically available.
Summary
In sum, AI holds strong potential to improve the lives of those living with epilepsy, possibly reducing the unpredictability of epilepsy, minimizing its physical and emotional toll, and improving outcomes for people of every age living with the condition. Stay tuned because it looks like this is going to be occurring much sooner than any of us suspected just a few years ago.
